pI: 9.7132 |
Length (AA): 346 |
MW (Da): 38740 |
Paralog Number:
2
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 2
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Bloodstream Form. | Siegel TN |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | Procyclic. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_127110)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G25380 | NAD+ transporter 2 |
Arabidopsis thaliana | AT2G47490 | NAD+ transporter 1 |
Arabidopsis thaliana | AT5G66380 | folate transporter 1 |
Babesia bovis | BBOV_III006870 | mitochondrial carrier protein, putative |
Brugia malayi | Bm1_20990 | Mitochondrial carrier protein |
Candida albicans | CaO19_6532 | hypothetical protein |
Candida albicans | CaO19.8971 | likely mitochondrial carrier protein similar to S. cerevisiae YIL006W |
Candida albicans | CaO19.1393 | likely mitochondrial carrier protein similar to S. cerevisiae YIL006W |
Candida albicans | CaO19.6532 | likely mitochondrial carrier protein similar to S. cerevisiae FLX1 (YIL134W) FAD carrier protein |
Candida albicans | CaO19.13885 | likely mitochondrial carrier protein similar to S. cerevisiae FLX1 (YIL134W) FAD carrier protein |
Caenorhabditis elegans | CELE_K01C8.7 | Protein K01C8.7, isoform B |
Cryptosporidium hominis | Chro.10266 | ENSANGP00000009305 |
Cryptosporidium parvum | cgd1_2370 | mitochondrial carrier protein, Flx1p like mitochondrial membrane associated flavin transporter with 4 or more transmembrane doma |
Dictyostelium discoideum | DDB_G0290669 | mitochondrial substrate carrier family protein |
Dictyostelium discoideum | DDB_G0283751 | mitochondrial substrate carrier family protein |
Drosophila melanogaster | Dmel_CG8026 | CG8026 gene product from transcript CG8026-RD |
Echinococcus granulosus | EgrG_000964400 | mitochondrial folate transporter:carrier |
Echinococcus multilocularis | EmuJ_000964400 | mitochondrial folate transporter:carrier |
Homo sapiens | ENSG00000164933 | solute carrier family 25 (mitochondrial folate carrier), member 32 |
Leishmania braziliensis | LbrM.34.3240 | mitochondrial carrier protein, putative |
Leishmania braziliensis | LbrM.32.1210 | mitochondrial carrier protein, putative |
Leishmania braziliensis | LbrM.32.1220 | mitochondrial carrier protein-like protein |
Leishmania donovani | LdBPK_321180.1 | mitochondrial carrier protein-like protein |
Leishmania donovani | LdBPK_321170.1 | mitochondrial carrier protein, putative |
Leishmania donovani | LdBPK_353380.1 | mitochondrial carrier protein, putative |
Leishmania infantum | LinJ.32.1180 | mitochondrial carrier protein-like protein |
Leishmania infantum | LinJ.35.3380 | mitochondrial carrier protein, putative |
Leishmania infantum | LinJ.32.1170 | mitochondrial carrier protein, putative,mitochondrial pyruvate carrier-like protein |
Leishmania major | LmjF.35.3330 | mitochondrial carrier protein, putative |
Leishmania major | LmjF.32.1110 | mitochondrial carrier protein, putative,mitochondrial pyruvate carrier-like protein |
Leishmania major | LmjF.32.1120 | mitochondrial carrier protein-like protein |
Leishmania mexicana | LmxM.31.1110 | mitochondrial carrier protein, putative,mitochondrial pyruvate carrier-like protein |
Leishmania mexicana | LmxM.31.1120 | mitochondrial carrier protein-like protein |
Leishmania mexicana | LmxM.34.3330 | mitochondrial carrier protein, putative |
Loa Loa (eye worm) | LOAG_04603 | hypothetical protein |
Mus musculus | ENSMUSG00000022299 | solute carrier family 25, member 32 |
Neospora caninum | NCLIV_022040 | mitochondrial carrier domain-containing protein, putative |
Neospora caninum | NCLIV_044910 | Os03g0734700 protein, related |
Oryza sativa | 4323984 | Os01g0513200 |
Oryza sativa | 9266735 | Os01g0513301 |
Oryza sativa | 4334018 | Os03g0734700 |
Oryza sativa | 4338524 | Os05g0357200 |
Onchocerca volvulus | OVOC2218 | Mitochondrial folate transporter\/carrier homolog |
Saccharomyces cerevisiae | YIL134W | Flx1p |
Saccharomyces cerevisiae | YIL006W | Yia6p |
Saccharomyces cerevisiae | YEL006W | Yea6p |
Schistosoma japonicum | Sjp_0313780 | Mitochondrial folate transporter/carrier, putative |
Schistosoma mansoni | Smp_044020 | folate carrier protein |
Schmidtea mediterranea | mk4.006619.00 | Mitochondrial folate transporter/carrier |
Schmidtea mediterranea | mk4.001995.03 | Mitochondrial folate transporter/carrier |
Trypanosoma brucei gambiense | Tbg972.11.16080 | mitochondrial carrier protein, putative |
Trypanosoma brucei gambiense | Tbg972.9.7360 | mitochondrial carrier protein, putative |
Trypanosoma brucei gambiense | Tbg972.11.16100 | mitochondrial carrier protein, putative |
Trypanosoma brucei | Tb927.11.14350 | mitochondrial carrier protein |
Trypanosoma brucei | Tb927.11.14360 | mitochondrial carrier protein |
Trypanosoma brucei | Tb927.9.12140 | mitochondrial carrier protein |
Trypanosoma congolense | TcIL3000_9_5000 | mitochondrial carrier protein, putative |
Trypanosoma congolense | TcIL3000.11.14690 | mitochondrial carrier protein |
Trypanosoma congolense | TcIL3000.11.14680 | mitochondrial carrier protein |
Trypanosoma cruzi | TcCLB.511725.140 | mitochondrial carrier protein, putative |
Trypanosoma cruzi | TcCLB.510737.30 | mitochondrial carrier protein, putative |
Trypanosoma cruzi | TcCLB.510663.64 | mitochondrial carrier protein, putative |
Trypanosoma cruzi | TcCLB.511725.134 | mitochondrial carrier protein, putative |
Toxoplasma gondii | TGME49_228680 | mitochondrial carrier superfamily protein |
Theileria parva | TP04_0593 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.5950 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.5950 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.5950 this record | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb11.01.5950 this record | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb11.01.5960 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.5960 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.5960 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.5960 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb09.211.3200 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb09.211.3200 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb09.211.3200 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb09.211.3200 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_K01C8.7 | Caenorhabditis elegans | slow growth | wormbase |
TGME49_228680 | Toxoplasma gondii | Essentiality uncertain | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | increased (PATO:0000470) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | increased cell proliferation (significant gain of fitness) in procyclic forms . | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.5
1 literature reference was collected for this gene.